ArticleMolecular cancer therapeutics2026

Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells.

Sidharth N Gadgil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.